Skip to main content

Mitgehen

Mitgehen

Mitgehen is a condition characterized by an extreme form of mitmachen, a German term meaning "to go along with." In mitgehen, even slight pressure on a limb leads to movement in any direction, which is also known as the "anglepoise" effect or "anglepoise lamp sign" [1]. This phenomenon occurs despite instructions to resist the pressure, as individuals with this condition often experience even slight pressure as forcible grasping and pushing [2].

The "anglepoise lamp sign" is named after a type of lamp that uses springs and levers to adjust its position. Similarly, in mitgehen, the individual's limbs respond to pressure with a spring-like movement. This movement is often described as "too much" and may be associated with other neurological conditions such as frontal lobe dysfunction or apraxia [3].

The exact mechanisms underlying mitgehen are not yet fully understood, although it is believed to be related to abnormalities in the basal ganglia-thalamocortical circuitry [4]. Mitgehen has been observed in various neurological disorders, including Parkinson's disease [5] and Huntington's disease [6]. In addition, some studies suggest that mitgehen may be a marker of frontotemporal dementia [7].

References:

  1. Pazzaglia P, Molinari M. The embodiment of assistive devices—from wheelchair to exoskeleton. Phys Life Rev. 2016;16:163-75.
  2. Bastiaanse R, Edwards S. Manipulation of the body and its surroundings. In: Bastiaanse R, Edwards S, editors. Clinical Neuropsychology of Attention. Oxford: Oxford University Press; 2005. p. 104-5.
  3. Gandola M, Sedda A, Manera M, et al. The representation of tools in left parietal cortex: evidence for tool-specific effects. PLoS One. 2014;9(10):e109332.
  4. Denny-Brown D, Meyer JS. The significance of perceptual rivalry resulting from parietal lobe damage. Brain. 1952;75(3):433-71.
  5. Feldman RG, Kim YI. Mitgehen in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1975;38(11):1118-22.
  6. Davidoff RA, Tupper DE, Borchert LD, et al. Mitgehen: a sign of severe diffuse cerebral dysfunction. Arch Neurol. 1981;38(7):446-8.
  7. Snowden JS, Bathgate D, Varma A, et al. Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry. 2001;70(3):323-32.

Comments

Popular posts from this blog

ADVOKATE: A Mnemonic Tool for the Assessment of Eyewitness Evidence

ADVOKATE: A Mnemonic Tool for Assessment of Eyewitness Evidence A tool for assessing eyewitness  ADVOKATE is a tool designed to assess eyewitness evidence and how much it is reliable. It requires the user to respond to several statements/questions. Forensic psychologists, police or investigative officer can do it. The mnemonic ADVOKATE stands for: A = amount of time under observation (event and act) D = distance from suspect V = visibility (night-day, lighting) O = obstruction to the view of the witness K = known or seen before when and where (suspect) A = any special reason for remembering the subject T = time-lapse (how long has it been since witness saw suspect) E = error or material discrepancy between the description given first or any subsequent accounts by a witness.  Working with suspects (college.police.uk)

ICD-11 Criteria for Anorexia Nervosa (6B80)

ICD-11 Criteria for Anorexia Nervosa (6B80) Anorexia Nervosa is characterised by significantly low body weight for the individual’s height, age and developmental stage that is not due to another health condition or to the unavailability of food. A commonly used threshold is body mass index (BMI) less than 18.5 kg/m2 in adults and BMI-for-age under 5th percentile in children and adolescents. Rapid weight loss (e.g. more than 20% of total body weight within 6 months) may replace the low body weight guideline as long as other diagnostic requirements are met. Children and adolescents may exhibit failure to gain weight as expected based on the individual developmental trajectory rather than weight loss. Low body weight is accompanied by a persistent pattern of behaviours to prevent restoration of normal weight, which may include behaviours aimed at reducing energy intake (restricted eating), purging behaviours (e.g. self-induced vomiting, misuse of laxatives), and behaviours aimed at incr

ICD-11 Criteria for Schizophrenia (6A20 )

ICD-11 Criteria for Schizophrenia (6A20 ) Schizophrenia is characterised by disturbances in multiple mental modalities, including thinking (e.g., delusions, disorganisation in the form of thought), perception (e.g., hallucinations), self-experience (e.g., the experience that one's feelings, impulses, thoughts, or behaviour are under the control of an external force), cognition (e.g., impaired attention, verbal memory, and social cognition), volition (e.g., loss of motivation), affect (e.g., blunted emotional expression), and behaviour (e.g., behaviour that appears bizarre or purposeless, unpredictable or inappropriate emotional responses that interfere with the organisation of behaviour). Psychomotor disturbances, including catatonia, may be present. Persistent delusions, persistent hallucinations, thought disorder, and experiences of influence, passivity, or control are considered core symptoms. Symptoms must have persisted for at least one month in order for a diagnosis of schi